Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|April 26, 2021
Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303Takahiro Mimae, Hisashi Saji, Hiroshige Nakamura, et al.
Clinical Lung Cancer|October 25, 2021
Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303Masayuki Nakao, Hisashi Saji, Mingoyn Mun, et al.
The Annals of Thoracic Surgery|April 2, 2023
Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter StudyTakahiro Mimae, Hisashi Saji, Hiroshige Nakamura, et al.
Anticancer Research|December 25, 2016
Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the LungYohei Yurugi, Makoto Wakahara, Yuki Matsuoka, et al.
Translational Lung Cancer Research|March 15, 2018
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypesWei Zhang, Luc Girard, Yu-An Zhang, et al.
Surgery Today|February 25, 2022
The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303Takuro Miyazaki, Hisashi Saji, Hiroshige Nakamura, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2024
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trialKazuya Takamochi, Tomohiro Haruki, Shiaki Oh, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303Hisashi Saji, Takahiko Ueno, Hiroshige Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2025
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumorsKazuya Takamochi, Kenji Suzuki, Morihito Okada, et al.
JTCVS Open|May 4, 2026
Induction chemotherapy plus bevacizumab or radiotherapy in N2 non-squamous non-small cell lung cancer: 5-year results of a randomized phase 2 trialKazuya Takamochi, Kenji Suzuki, Masahiro Tsuboi, et al.
Pageof 10